Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.
3don MSN
Social media posts claimed Donald Trump and Elon Musk had simply "learned from the master" in their attempts to cut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback